Opportunity Information: Apply for RFA DC 23 002
The NIDCD National Human Ear Resource Network (RFA-DC-23-002) is a National Institutes of Health funding opportunity designed to support several laboratories in forming a coordinated, collaborative network that serves as a national technology and service resource for scientists studying hearing and balance. The core purpose is to strengthen and expand the research communitys ability to use post-mortem human inner and middle ear tissues, especially human temporal bones, in both basic and clinically oriented studies. By building shared capacity and common standards across multiple labs, the program aims to make high-quality human ear specimens and related technical expertise more accessible, more consistent, and easier to integrate into research pipelines that currently rely heavily on animal models.
A central feature of the initiative is the creation of a service-oriented infrastructure. Network laboratories are expected to provide technical services covering the full chain of human ear tissue resource work: procuring temporal bones and other relevant tissues, preparing and preserving specimens, sectioning tissues appropriately for downstream assays, and distributing high-quality materials to qualified researchers. The FOA emphasizes improving and disseminating methods, not just maintaining existing practices. That includes developing and sharing better approaches to tissue preservation and processing, as well as optimizing visualization methods for human middle and inner ear structures, including delicate cellular and membranous components that are often difficult to preserve and interpret. In practical terms, the Network is meant to make it easier for outside investigators to obtain well-processed specimens and to use modern, reliable protocols that can support histology, imaging, and other analytic approaches.
Another major goal is broad dissemination of data and training. Network labs will digitize temporal bone images and upload them into NIDCD-approved databases so the wider community can access and use these materials. The program also calls for technical instruction opportunities focused on the specialized skills required to recover and process ear tissues from post-mortem temporal bones, which are notoriously challenging specimens. Beyond the bench-level work, the Network is expected to do active outreach to scientific and clinical audiences to encourage wider adoption of human temporal bone resources, connect researchers with Network capabilities, and foster collaboration between Network and non-Network laboratories. The intent is to reduce fragmentation in the field, increase awareness of available resources, and grow the overall user base for human ear tissues in auditory and vestibular research.
The award mechanism is a U24 cooperative agreement, meaning NIH anticipates substantial involvement in coordinating activities and ensuring the network functions as a coherent national resource rather than a collection of independent projects. A key expectation is coordination across participating laboratories to maximize national impact and avoid duplicative efforts, such as redundant protocol development or overlapping infrastructure where shared solutions would be more efficient. While the focus is strongly resource- and service-based, the FOA also allows individual laboratories to propose research components aimed at improving current techniques for processing and using human temporal bones, so long as those improvements clearly support the broader resource mission. Clinical trials are not allowed under this opportunity.
Eligibility is broad across many domestic organization types, reflecting the programmatic goal of building widely accessible national infrastructure. Eligible applicants include state, county, and local governments; public and private institutions of higher education; federally recognized tribal governments and other tribal organizations; nonprofits with or without 501(c)(3) status; for-profit organizations other than small businesses; and small businesses, among others. The FOA also highlights additional eligible applicant categories such as HBCUs, Hispanic-serving institutions, tribally controlled colleges and universities, Alaska Native and Native Hawaiian-serving institutions, and AANAPISI institutions, as well as faith-based or community-based organizations and U.S. territories or possessions. Non-U.S. (foreign) institutions are not eligible to apply as applicant organizations, but non-domestic components of U.S. organizations may participate, and foreign components are allowed as defined by NIH policy.
Administratively, the opportunity is run by NIH under CFDA 93.173, categorized as discretionary funding in the health area, and uses the cooperative agreement funding instrument. The original closing date listed for the opportunity was April 6, 2022, and the FOA was created February 11, 2022. Overall, the program is structured to accelerate translation from animal and in vitro findings to human biology by making well-characterized human ear tissues, high-quality imaging resources, and specialized know-how available at national scale, directly supporting NIDCDs mission areas in hearing, balance, and related communication disorders.Apply for RFA DC 23 002
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIDCD National Human Ear Resource Network (U24 Clinical Trial Not Allowed)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.173.
- This funding opportunity was created on 2022-02-11.
- Applicants must submit their applications by 2022-04-06. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Health
Next opportunity: Maximizing the Scientific Value of the NHLBI Biologic Biospecimen Repository: Scientific Opportunities for Exploratory Research (R21)
Previous opportunity: FY 2022 National Infrastructure Investments
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DC 23 002
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DC 23 002) also looked into and applied for these:
| Funding Opportunity |
|---|
| Limited Competition: NEI - DOD Vision Research Collaborative (R01 Clinical Trial Optional) Apply for PAR 22 117 Funding Number: PAR 22 117 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Data Management and Coordinating Center (DMCC) for the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRC) (U24 Basic Experimental Studies with Humans Required) Apply for RFA NS 22 020 Funding Number: RFA NS 22 020 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRCs) (U54, Basic Experimental Studies Involving Humans Allowed) Apply for RFA NS 22 019 Funding Number: RFA NS 22 019 Agency: National Institutes of Health Category: Health Funding Amount: $1,200,000 |
| In utero Treatments of Congenital Dental and Craniofacial Disorders Using Precision Medicine Approaches (R21 Clinical Trial Not Allowed) Apply for RFA DE 23 005 Funding Number: RFA DE 23 005 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| In utero Treatments of Congenital Dental and Craniofacial Disorders Using Precision Medicine Approaches (R01 Clinical Trial Not Allowed) Apply for RFA DE 23 004 Funding Number: RFA DE 23 004 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Guinea Local Health System Strengthening (GLHSS) Apply for 72067522APS00002 Funding Number: 72067522APS00002 Agency: Guinea USAID-Conakry Category: Health Funding Amount: Case Dependent |
| Limited Competition: Transformative Research to Address Health Disparities and Advance Health Equity at Minority Serving Institutions (U01 Clinical Trial Optional) Apply for RFA RM 22 001 Funding Number: RFA RM 22 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional) Apply for RFA RM 22 008 Funding Number: RFA RM 22 008 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Health Equity and the Cost of Novel Treatments for Alzheimers Disease and Related Dementias (R61/R33 Clinical Trial Not Allowed) Apply for RFA AG 23 005 Funding Number: RFA AG 23 005 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Mechanisms of Brain Hypoperfusion in AD/ADRD (R01 Clinical Trial Not Allowed) Apply for RFA AG 23 014 Funding Number: RFA AG 23 014 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Team-Based Design in Biomedical Engineering Education (R25 Clinical Trial Not Allowed) Apply for PAR 22 000 Funding Number: PAR 22 000 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Maximizing the Scientific Value of the NHLBI Biologic Biospecimen Repository: Scientific Opportunities for Exploratory Research (R21) Apply for RFA HL 23 018 Funding Number: RFA HL 23 018 Agency: National Institutes of Health Category: Health Funding Amount: $75,000 |
| Development of Biomarkers or Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional) Apply for PAR 22 089 Funding Number: PAR 22 089 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Screening for Cognitive Impairment: Decision-Making (U24 Clinical Trial Optional) Apply for RFA AG 23 007 Funding Number: RFA AG 23 007 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Somatic Mosaicism across Human Tissues (SMaHT) Program: Tool Development Projects (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA RM 22 011 Funding Number: RFA RM 22 011 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Somatic Mosaicism across Human Tissues (SMaHT) Program: Organizational Center (U24 Clinical Trial Not Allowed) Apply for RFA RM 22 009 Funding Number: RFA RM 22 009 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Somatic Mosaicism across Human Tissues (SMaHT) Program: Data Analysis Center (UM1 Clinical Trial Not Allowed) Apply for RFA RM 22 010 Funding Number: RFA RM 22 010 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Immune Drivers of Autoimmune Disease (IDAD) (U01 Clinical Trial Not Allowed) Apply for RFA AI 22 012 Funding Number: RFA AI 22 012 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
| Somatic Mosaicism across Human Tissues (SMaHT) Program: Genome Characterization Centers (UM1 Clinical Trial Not Allowed) Apply for RFA RM 22 013 Funding Number: RFA RM 22 013 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Somatic Mosaicism across Human Tissues (SMaHT) Program: Tissue Procurement Center (U24 Clinical Trial Not Allowed) Apply for RFA RM 22 012 Funding Number: RFA RM 22 012 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DC 23 002", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
